0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global FABP1 Antibody Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37C9957
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global FABP1 Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global FABP1 Antibody Market Research Report 2025

Code: QYRE-Auto-37C9957
Report
July 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

FABP1 Antibody Market Size

The global market for FABP1 Antibody was valued at US$ 70.8 million in the year 2024 and is projected to reach a revised size of US$ 249 million by 2031, growing at a CAGR of 20.0% during the forecast period.

FABP1 Antibody Market

FABP1 Antibody Market

Antibodies are proteins that protect you when an unwanted substance enters your body.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for FABP1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FABP1 Antibody.
The FABP1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global FABP1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FABP1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of FABP1 Antibody Market Report

Report Metric Details
Report Name FABP1 Antibody Market
Accounted market size in year US$ 70.8 million
Forecasted market size in 2031 US$ 249 million
CAGR 20.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Cell Signaling Technology, Abcam, Santa Cruz Biotechnology, Boster Biological Technology, Aviva Systems Biology, CUSABIO, ProSci, Affinity Biosciences, Abnova, NSJ Bioreagents, BioLegend, G Biosciences, Merck, Proteintech, United States Biological, FineTest
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of FABP1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of FABP1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is FABP1 Antibody Market growing?

Ans: The FABP1 Antibody Market witnessing a CAGR of 20.0% during the forecast period 2025-2031.

What is the FABP1 Antibody Market size in 2031?

Ans: The FABP1 Antibody Market size in 2031 will be US$ 249 million.

Who are the main players in the FABP1 Antibody Market report?

Ans: The main players in the FABP1 Antibody Market are Thermo Fisher Scientific, Cell Signaling Technology, Abcam, Santa Cruz Biotechnology, Boster Biological Technology, Aviva Systems Biology, CUSABIO, ProSci, Affinity Biosciences, Abnova, NSJ Bioreagents, BioLegend, G Biosciences, Merck, Proteintech, United States Biological, FineTest

What are the Application segmentation covered in the FABP1 Antibody Market report?

Ans: The Applications covered in the FABP1 Antibody Market report are Immunofluorescence, Immunohistochemistry, Western Blot, Others

What are the Type segmentation covered in the FABP1 Antibody Market report?

Ans: The Types covered in the FABP1 Antibody Market report are Polyclonal, Monoclonal

Recommended Reports

Antibody Markets

Monoclonal & Recombinant

Specialty & Functional

1 FABP1 Antibody Market Overview
1.1 Product Definition
1.2 FABP1 Antibody by Type
1.2.1 Global FABP1 Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 FABP1 Antibody by Application
1.3.1 Global FABP1 Antibody Market Value by Application (2024 VS 2031)
1.3.2 Immunofluorescence
1.3.3 Immunohistochemistry
1.3.4 Western Blot
1.3.5 Others
1.4 Global FABP1 Antibody Market Size Estimates and Forecasts
1.4.1 Global FABP1 Antibody Revenue 2020-2031
1.4.2 Global FABP1 Antibody Sales 2020-2031
1.4.3 Global FABP1 Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 FABP1 Antibody Market Competition by Manufacturers
2.1 Global FABP1 Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global FABP1 Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global FABP1 Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of FABP1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of FABP1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of FABP1 Antibody, Product Type & Application
2.7 Global Key Manufacturers of FABP1 Antibody, Date of Enter into This Industry
2.8 Global FABP1 Antibody Market Competitive Situation and Trends
2.8.1 Global FABP1 Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest FABP1 Antibody Players Market Share by Revenue
2.8.3 Global FABP1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FABP1 Antibody Market Scenario by Region
3.1 Global FABP1 Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global FABP1 Antibody Sales by Region: 2020-2031
3.2.1 Global FABP1 Antibody Sales by Region: 2020-2025
3.2.2 Global FABP1 Antibody Sales by Region: 2026-2031
3.3 Global FABP1 Antibody Revenue by Region: 2020-2031
3.3.1 Global FABP1 Antibody Revenue by Region: 2020-2025
3.3.2 Global FABP1 Antibody Revenue by Region: 2026-2031
3.4 North America FABP1 Antibody Market Facts & Figures by Country
3.4.1 North America FABP1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America FABP1 Antibody Sales by Country (2020-2031)
3.4.3 North America FABP1 Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe FABP1 Antibody Market Facts & Figures by Country
3.5.1 Europe FABP1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe FABP1 Antibody Sales by Country (2020-2031)
3.5.3 Europe FABP1 Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FABP1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific FABP1 Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific FABP1 Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific FABP1 Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America FABP1 Antibody Market Facts & Figures by Country
3.7.1 Latin America FABP1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America FABP1 Antibody Sales by Country (2020-2031)
3.7.3 Latin America FABP1 Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa FABP1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa FABP1 Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa FABP1 Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa FABP1 Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FABP1 Antibody Sales by Type (2020-2031)
4.1.1 Global FABP1 Antibody Sales by Type (2020-2025)
4.1.2 Global FABP1 Antibody Sales by Type (2026-2031)
4.1.3 Global FABP1 Antibody Sales Market Share by Type (2020-2031)
4.2 Global FABP1 Antibody Revenue by Type (2020-2031)
4.2.1 Global FABP1 Antibody Revenue by Type (2020-2025)
4.2.2 Global FABP1 Antibody Revenue by Type (2026-2031)
4.2.3 Global FABP1 Antibody Revenue Market Share by Type (2020-2031)
4.3 Global FABP1 Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global FABP1 Antibody Sales by Application (2020-2031)
5.1.1 Global FABP1 Antibody Sales by Application (2020-2025)
5.1.2 Global FABP1 Antibody Sales by Application (2026-2031)
5.1.3 Global FABP1 Antibody Sales Market Share by Application (2020-2031)
5.2 Global FABP1 Antibody Revenue by Application (2020-2031)
5.2.1 Global FABP1 Antibody Revenue by Application (2020-2025)
5.2.2 Global FABP1 Antibody Revenue by Application (2026-2031)
5.2.3 Global FABP1 Antibody Revenue Market Share by Application (2020-2031)
5.3 Global FABP1 Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific FABP1 Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Cell Signaling Technology
6.2.1 Cell Signaling Technology Company Information
6.2.2 Cell Signaling Technology Description and Business Overview
6.2.3 Cell Signaling Technology FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cell Signaling Technology FABP1 Antibody Product Portfolio
6.2.5 Cell Signaling Technology Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam FABP1 Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 Santa Cruz Biotechnology
6.4.1 Santa Cruz Biotechnology Company Information
6.4.2 Santa Cruz Biotechnology Description and Business Overview
6.4.3 Santa Cruz Biotechnology FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Santa Cruz Biotechnology FABP1 Antibody Product Portfolio
6.4.5 Santa Cruz Biotechnology Recent Developments/Updates
6.5 Boster Biological Technology
6.5.1 Boster Biological Technology Company Information
6.5.2 Boster Biological Technology Description and Business Overview
6.5.3 Boster Biological Technology FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boster Biological Technology FABP1 Antibody Product Portfolio
6.5.5 Boster Biological Technology Recent Developments/Updates
6.6 Aviva Systems Biology
6.6.1 Aviva Systems Biology Company Information
6.6.2 Aviva Systems Biology Description and Business Overview
6.6.3 Aviva Systems Biology FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aviva Systems Biology FABP1 Antibody Product Portfolio
6.6.5 Aviva Systems Biology Recent Developments/Updates
6.7 CUSABIO
6.7.1 CUSABIO Company Information
6.7.2 CUSABIO Description and Business Overview
6.7.3 CUSABIO FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CUSABIO FABP1 Antibody Product Portfolio
6.7.5 CUSABIO Recent Developments/Updates
6.8 ProSci
6.8.1 ProSci Company Information
6.8.2 ProSci Description and Business Overview
6.8.3 ProSci FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ProSci FABP1 Antibody Product Portfolio
6.8.5 ProSci Recent Developments/Updates
6.9 Affinity Biosciences
6.9.1 Affinity Biosciences Company Information
6.9.2 Affinity Biosciences Description and Business Overview
6.9.3 Affinity Biosciences FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Affinity Biosciences FABP1 Antibody Product Portfolio
6.9.5 Affinity Biosciences Recent Developments/Updates
6.10 Abnova
6.10.1 Abnova Company Information
6.10.2 Abnova Description and Business Overview
6.10.3 Abnova FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abnova FABP1 Antibody Product Portfolio
6.10.5 Abnova Recent Developments/Updates
6.11 NSJ Bioreagents
6.11.1 NSJ Bioreagents Company Information
6.11.2 NSJ Bioreagents Description and Business Overview
6.11.3 NSJ Bioreagents FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 NSJ Bioreagents FABP1 Antibody Product Portfolio
6.11.5 NSJ Bioreagents Recent Developments/Updates
6.12 BioLegend
6.12.1 BioLegend Company Information
6.12.2 BioLegend Description and Business Overview
6.12.3 BioLegend FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BioLegend FABP1 Antibody Product Portfolio
6.12.5 BioLegend Recent Developments/Updates
6.13 G Biosciences
6.13.1 G Biosciences Company Information
6.13.2 G Biosciences Description and Business Overview
6.13.3 G Biosciences FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 G Biosciences FABP1 Antibody Product Portfolio
6.13.5 G Biosciences Recent Developments/Updates
6.14 Merck
6.14.1 Merck Company Information
6.14.2 Merck Description and Business Overview
6.14.3 Merck FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merck FABP1 Antibody Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 Proteintech
6.15.1 Proteintech Company Information
6.15.2 Proteintech Description and Business Overview
6.15.3 Proteintech FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Proteintech FABP1 Antibody Product Portfolio
6.15.5 Proteintech Recent Developments/Updates
6.16 United States Biological
6.16.1 United States Biological Company Information
6.16.2 United States Biological Description and Business Overview
6.16.3 United States Biological FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.16.4 United States Biological FABP1 Antibody Product Portfolio
6.16.5 United States Biological Recent Developments/Updates
6.17 FineTest
6.17.1 FineTest Company Information
6.17.2 FineTest Description and Business Overview
6.17.3 FineTest FABP1 Antibody Sales, Revenue and Gross Margin (2020-2025)
6.17.4 FineTest FABP1 Antibody Product Portfolio
6.17.5 FineTest Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FABP1 Antibody Industry Chain Analysis
7.2 FABP1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FABP1 Antibody Production Mode & Process Analysis
7.4 FABP1 Antibody Sales and Marketing
7.4.1 FABP1 Antibody Sales Channels
7.4.2 FABP1 Antibody Distributors
7.5 FABP1 Antibody Customer Analysis
8 FABP1 Antibody Market Dynamics
8.1 FABP1 Antibody Industry Trends
8.2 FABP1 Antibody Market Drivers
8.3 FABP1 Antibody Market Challenges
8.4 FABP1 Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global FABP1 Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global FABP1 Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global FABP1 Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global FABP1 Antibody Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global FABP1 Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global FABP1 Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global FABP1 Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market FABP1 Antibody Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of FABP1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of FABP1 Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of FABP1 Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of FABP1 Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global FABP1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FABP1 Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global FABP1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global FABP1 Antibody Sales by Region (2020-2025) & (Kg)
 Table 18. Global FABP1 Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global FABP1 Antibody Sales by Region (2026-2031) & (Kg)
 Table 20. Global FABP1 Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global FABP1 Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global FABP1 Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global FABP1 Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global FABP1 Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America FABP1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America FABP1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 27. North America FABP1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 28. North America FABP1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America FABP1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe FABP1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe FABP1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 32. Europe FABP1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 33. Europe FABP1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe FABP1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific FABP1 Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific FABP1 Antibody Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific FABP1 Antibody Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific FABP1 Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific FABP1 Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America FABP1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America FABP1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America FABP1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America FABP1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America FABP1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa FABP1 Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa FABP1 Antibody Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa FABP1 Antibody Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa FABP1 Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa FABP1 Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global FABP1 Antibody Sales (Kg) by Type (2020-2025)
 Table 51. Global FABP1 Antibody Sales (Kg) by Type (2026-2031)
 Table 52. Global FABP1 Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global FABP1 Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global FABP1 Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global FABP1 Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global FABP1 Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global FABP1 Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global FABP1 Antibody Price (US$/Kg) by Type (2020-2025)
 Table 59. Global FABP1 Antibody Price (US$/Kg) by Type (2026-2031)
 Table 60. Global FABP1 Antibody Sales (Kg) by Application (2020-2025)
 Table 61. Global FABP1 Antibody Sales (Kg) by Application (2026-2031)
 Table 62. Global FABP1 Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global FABP1 Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global FABP1 Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global FABP1 Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global FABP1 Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global FABP1 Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global FABP1 Antibody Price (US$/Kg) by Application (2020-2025)
 Table 69. Global FABP1 Antibody Price (US$/Kg) by Application (2026-2031)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Scientific FABP1 Antibody Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Cell Signaling Technology Company Information
 Table 76. Cell Signaling Technology Description and Business Overview
 Table 77. Cell Signaling Technology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Cell Signaling Technology FABP1 Antibody Product
 Table 79. Cell Signaling Technology Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Abcam FABP1 Antibody Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. Santa Cruz Biotechnology Company Information
 Table 86. Santa Cruz Biotechnology Description and Business Overview
 Table 87. Santa Cruz Biotechnology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Santa Cruz Biotechnology FABP1 Antibody Product
 Table 89. Santa Cruz Biotechnology Recent Developments/Updates
 Table 90. Boster Biological Technology Company Information
 Table 91. Boster Biological Technology Description and Business Overview
 Table 92. Boster Biological Technology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Boster Biological Technology FABP1 Antibody Product
 Table 94. Boster Biological Technology Recent Developments/Updates
 Table 95. Aviva Systems Biology Company Information
 Table 96. Aviva Systems Biology Description and Business Overview
 Table 97. Aviva Systems Biology FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Aviva Systems Biology FABP1 Antibody Product
 Table 99. Aviva Systems Biology Recent Developments/Updates
 Table 100. CUSABIO Company Information
 Table 101. CUSABIO Description and Business Overview
 Table 102. CUSABIO FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. CUSABIO FABP1 Antibody Product
 Table 104. CUSABIO Recent Developments/Updates
 Table 105. ProSci Company Information
 Table 106. ProSci Description and Business Overview
 Table 107. ProSci FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. ProSci FABP1 Antibody Product
 Table 109. ProSci Recent Developments/Updates
 Table 110. Affinity Biosciences Company Information
 Table 111. Affinity Biosciences Description and Business Overview
 Table 112. Affinity Biosciences FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Affinity Biosciences FABP1 Antibody Product
 Table 114. Affinity Biosciences Recent Developments/Updates
 Table 115. Abnova Company Information
 Table 116. Abnova Description and Business Overview
 Table 117. Abnova FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Abnova FABP1 Antibody Product
 Table 119. Abnova Recent Developments/Updates
 Table 120. NSJ Bioreagents Company Information
 Table 121. NSJ Bioreagents Description and Business Overview
 Table 122. NSJ Bioreagents FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. NSJ Bioreagents FABP1 Antibody Product
 Table 124. NSJ Bioreagents Recent Developments/Updates
 Table 125. BioLegend Company Information
 Table 126. BioLegend Description and Business Overview
 Table 127. BioLegend FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. BioLegend FABP1 Antibody Product
 Table 129. BioLegend Recent Developments/Updates
 Table 130. G Biosciences Company Information
 Table 131. G Biosciences Description and Business Overview
 Table 132. G Biosciences FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 133. G Biosciences FABP1 Antibody Product
 Table 134. G Biosciences Recent Developments/Updates
 Table 135. Merck Company Information
 Table 136. Merck Description and Business Overview
 Table 137. Merck FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 138. Merck FABP1 Antibody Product
 Table 139. Merck Recent Developments/Updates
 Table 140. Proteintech Company Information
 Table 141. Proteintech Description and Business Overview
 Table 142. Proteintech FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 143. Proteintech FABP1 Antibody Product
 Table 144. Proteintech Recent Developments/Updates
 Table 145. United States Biological Company Information
 Table 146. United States Biological Description and Business Overview
 Table 147. United States Biological FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 148. United States Biological FABP1 Antibody Product
 Table 149. United States Biological Recent Developments/Updates
 Table 150. FineTest Company Information
 Table 151. FineTest Description and Business Overview
 Table 152. FineTest FABP1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 153. FineTest FABP1 Antibody Product
 Table 154. FineTest Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. FABP1 Antibody Distributors List
 Table 158. FABP1 Antibody Customers List
 Table 159. FABP1 Antibody Market Trends
 Table 160. FABP1 Antibody Market Drivers
 Table 161. FABP1 Antibody Market Challenges
 Table 162. FABP1 Antibody Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of FABP1 Antibody
 Figure 2. Global FABP1 Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global FABP1 Antibody Market Share by Type: 2024 & 2031
 Figure 4. Polyclonal Product Picture
 Figure 5. Monoclonal Product Picture
 Figure 6. Global FABP1 Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global FABP1 Antibody Market Share by Application: 2024 & 2031
 Figure 8. Immunofluorescence
 Figure 9. Immunohistochemistry
 Figure 10. Western Blot
 Figure 11. Others
 Figure 12. Global FABP1 Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global FABP1 Antibody Market Size (2020-2031) & (US$ Million)
 Figure 14. Global FABP1 Antibody Sales (2020-2031) & (Kg)
 Figure 15. Global FABP1 Antibody Average Price (US$/Kg) & (2020-2031)
 Figure 16. FABP1 Antibody Report Years Considered
 Figure 17. FABP1 Antibody Sales Share by Manufacturers in 2024
 Figure 18. Global FABP1 Antibody Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest FABP1 Antibody Players: Market Share by Revenue in FABP1 Antibody in 2024
 Figure 20. FABP1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global FABP1 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America FABP1 Antibody Sales Market Share by Country (2020-2031)
 Figure 23. North America FABP1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 24. United States FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe FABP1 Antibody Sales Market Share by Country (2020-2031)
 Figure 27. Europe FABP1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 28. Germany FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific FABP1 Antibody Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific FABP1 Antibody Revenue Market Share by Region (2020-2031)
 Figure 35. China FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America FABP1 Antibody Sales Market Share by Country (2020-2031)
 Figure 45. Latin America FABP1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa FABP1 Antibody Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa FABP1 Antibody Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE FABP1 Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of FABP1 Antibody by Type (2020-2031)
 Figure 55. Global Revenue Market Share of FABP1 Antibody by Type (2020-2031)
 Figure 56. Global FABP1 Antibody Price (US$/Kg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of FABP1 Antibody by Application (2020-2031)
 Figure 58. Global Revenue Market Share of FABP1 Antibody by Application (2020-2031)
 Figure 59. Global FABP1 Antibody Price (US$/Kg) by Application (2020-2031)
 Figure 60. FABP1 Antibody Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart